It's already FDA-approved to manage diabetes and obesity - now, researchers at UC San Diego have gotten it approved as the ...

The New York City Council on March 26 passed a bill that will require the New York City Department of Health and Mental Hygiene to establish a three-year pilot program that provides access to sleep ap ...

"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

OSA, a condition where the airway becomes blocked during sleep, often goes undiagnosed despite its serious health ...

The many reasons a person may sleepwalk include genetics, sleep deprivation, stress, migraines, fever, breathing disorders, ...

This review included 30 studies to analyze the potential for prolonged life in patients who use CPAP to treat obstructive sleep apnea.

Pollen allergies may be linked to an elevated risk for obstructive sleep apnea-hypopnea syndrome, a study shows.

It’s already FDA-approved to manage diabetes and obesity — now, researchers at UC San Diego have gotten it approved as the first effective drug therapy for sleep apnea. “Systolic blood ...